APYX Q1 2026 Earnings A NarrowerThanExpected Loss Led by Cost Discipline TTAN Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Recurring Revenue Growth CPHI Q3 2011 Earnings EPS Falls Short of Estimates Amid Challenging Environment Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure Helmerich Payne Q1 2026 Earnings Widerthanexpected loss weighs on shares PDEX Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction